Health and Wellness
The company will use the funds to expand its cloud-based automation platform for providers and pharmaceutical companies.
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
WellSpan Philhaven will add the digital health company's offerings to its suite of behavioral health services to support its primary care providers.
Caregivers can order rides and deliveries for their care recipients and pay for the service using the care receiver's health benefits.
Also, Optiscan is working with Mayo Clinic to develop a digital endomicroscopic imaging system for robotic surgery.
The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.
The launch of the WayFinding platform comes just weeks after the company announced it secured $126 million in funding.
Whole Health Rx will be powered by WellSync, which develops customizable telehealth services for businesses.